Paliperidone 3-Month IM Injection bulk supplier for pharma manufacturers

Paliperidone 3-Month Im Injection Suppliers & Bulk Manufacturers

Available Forms: Once-3-Month IM Injection

Available Strengths: 273 mg, 410 mg, 546 mg, 819 mg

Reference Brands: Trevicta®(EU); Invega Trinza®(US)

Paliperidone is an atypical antipsychotic that works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, helping to reduce psychotic symptoms and stabilize mood. The 3-month intramuscular injection is used for the maintenance treatment of schizophrenia in adults who are already stabilized on the 1-month formulation. It ensures consistent therapeutic levels, improves patient adherence, and lowers relapse risk by reducing dosing frequency to four times a year.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Paliperidone 3-Month Im Injection? List it or send an offer →

Product Description: Paliperidone 3-month intramuscular injection (brand name: Invega Trinza) is FDA-approved in the United States for the maintenance treatment of schizophrenia in adults who have been stabilized on Invega Sustenna (1-month formulation) for at least four months. In the European Union, it is centrally approved by the EMA with established Risk Management Plans (RMPs) and required pharmacovigilance activities. Regulatory compliance includes GMP-certified long-acting injectable manufacturing, bridging pharmacokinetic and safety data, and documentation for relapse prevention. U.S. labeling includes a boxed warning for elderly patients with dementia-related psychosis. Explore dossier-ready options at Pharmatradz.com — your global B2B pharma hub.

Paliperidone 3-Month Im Injection — third party manufacturing & bulk supply

Paliperidone 3-Month Im Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Paliperidone 3-Month Im Injection is supplied as Once-3-Month IM Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Paliperidone 3-Month Im Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Paliperidone 3-Month Im Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Paliperidone 3-Month IM Injection is listed as Once-3-Month IM Injection in 273 mg, 410 mg, 546 mg, 819 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Paliperidone 3-Month IM Injection is referenced against Trevicta®(EU); Invega Trinza®(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.